Which are critical to maintaining the health of the transplant patient.

Immunosuppressive drugs are covered for a period of 36 months. Because the drugs are so costly, when coverage is normally exhausted, many kidney recipients have no choice but to go without medication, compromising their health and the viability of the transplanted organ thereby. The homely house has included the provision to extend coverage in its health reform bill. AST is pushing the Senate to do the same. Related StoriesShorter sufferers receive lung transplants at lower ratesStudy suggests mix of MMF and CNIs can protect against rare lymphomaFindings reveal a fresh way to avoid meningitisThe AST letter, which can be read by likely to states that the provision will allow kidney recipients to keep up their life-saving donor organ and can reduce overall Medicare System costs, as the medicines are less expensive than dialysis.About 1 million people in the United States have had shock wave lithotripsy, says Dr. Segura.

AACE, AME and ETA jointly publish recommendations for diagnosis and administration of thyroid nodules Three of the world’s most respected medical associations for the treating thyroid disease recently issued joint guidelines for the analysis and administration of thyroid nodules. The American Association of Clinical Endocrinologists , the Associazione Medici Endocrinologi and European Thyroid Association jointly published the rules online this week, and the executive overview will be published within the next issue of their respective journals.